英語ページ

Publications 2011

  1. Habuchi, T. (2011) Role of lymph node dissection in managing urologic cancers. Int J. Clin. Oncol., 16, 169.
  2. Habuchi, T., Terachi, T., Mimata, H., Kondo, Y., Kanayama, H., Ichikawa, T., Nutahara, K., Miki, T., Ono, Y., Baba, S., Naito, S., & Matsuda, T. (2011) Evaluation of 2,590 urological laparoscopic surgeries undertaken by urological surgeons accredited by an endoscopic surgical skill qualification system in urological laparoscopy in Japan. Surg. Endosc., [2011 Dec 17.Epub ahead of print]
  3. Hatakeyama, S., Abe, A., Suzuki, T., Hashimoto, Y., Koie, T., Funyu, T., Satoh, S., Habuchi, T., Ohyama, C., and Matsuo, S. (2011) Clearance and safety of the radioconstrast medium iopamidol in peritoneal dialysis patients., Int. J. Nephrol., 2011, 657051.
  4. Frullanti, E., Berking, C., Harbeck, N., Jezequel, P., Haugen, A., Mawrin, C., Parise, O., Jr., Sasaki, H., Tsuchiya, N., Dragani, T. A. (2011) Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor. Eur J Cancer Prev., 20, 340-347.
  5. Huang, M., Narita, S., Tsuchiya, N., Ma Z., Numakura, K., Obara, T., Tsuruta, H., Saito, M., Inoue, T., Horikawa, Y., Satoh, S. and Habuchi, T. (2011) Overexpression of Fn14 promotes Androgen independent prostate cancer progression through MMP-9 and correlates with poor treatment outcome. Carcinogenesis., 32, 1589-96.
  6. Kote-Jarai, Z., Olama, A. A., Giles, G. G., Severi, G., Schleutker, J., Weischer, M., Campa, D., Riboli, E., Key, T., Gronberg, H., Hunter, D. J., Kraft, P., Thun, M. J., Ingles, S., Chanock, S., Albanes, D., Hayes, R. B., Neal, D. E., Hamdy, F. C., Donovan, J. L., Pharoah, P., Schumacher, F., Henderson, B. E., Stanford, J. L., Ostrander, E. A., Sorensen, K. D., Dork, T., Andriole, G., Dickinson, J. L., Cybulski, C., Lubinski, J., Spurdle, A., Clements, J. A., Chambers, S., Aitken, J., Gardiner, R. A., Thibodeau, S. N., Schaid, D., John, E. M., Maier, C., Vogel, W., Cooney, K. A., Park, J. Y., Cannon-Albright, L., Brenner, H., Habuchi, T., Zhang, H. W., Lu, Y. J., Kaneva, R., Muir, K., Benlloch, S., Leongamornlert, D. A., Saunders, E. J., Tymrakiewicz, M., Mahmud, N., Guy, M., O'Brien, L. T., Wilkinson, R. A., Hall, A. L., Sawyer, E. J., Dadaev, T., Morrison, J., Dearnaley, D. P., Horwich, A., Huddart, R. A., Khoo, V. S., Parker, C. C., Van As, N., Woodhouse, C. J., Thompson, A., Christmas, T., Ogden, C., Cooper, C. S., Lophatonanon, A., Southey, M. C., Hopper, J. L., English, D. R., Wahlfors, T., Tammela, T. L., Klarskov, P., Nordestgaard, B. G., Roder, M. A., Tybjaerg-Hansen, A., Bojesen, S. E., Travis, R., Canzian, F., Kaaks, R., Wiklund, F., Aly, M., Lindstrom, S., Diver, W. R., Gapstur, S., Stern, M. C., Corral, R., Virtamo, J., Cox, A., Haiman, C. A., Le Marchand, L., Fitzgerald, L., Kolb, S., Kwon, E. M., Karyadi, D. M., Orntoft, T. F., Borre, M., Meyer, A., Serth, J., Yeager, M., Berndt, S. I., Marthick, J. R., Patterson, B., Wokolorczyk, D., Batra, J., Lose, F., McDonnell, S. K., Joshi, A. D., Shahabi, A., Rinckleb, A. E., Ray, A., Sellers, T. A., Lin, H. Y., Stephenson, R. A., Farnham, J., Muller, H., Rothenbacher, D., Tsuchiya, N., Narita, S., Cao, G. W., Slavov, C., Mitev, V., Easton, D. F., Eeles, R. A. (2011) Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet., 43, 785-791.
  7. Miura, M., Niioka, T., Kagaya, H., Saito, M., Hayakari, M., Habuchi, T. and Satoh, S. (2011) Pharmacogenetic determinants for interindividual difference of tacrolimus pharmacokinetics 1 year after renal transplantation. J Clin Pharm Ther., 36, 208-216.
  8. Miura, M., Niioka, T., Kato, S., Kagaya, H., Saito, M., Habuchi, T. and Satoh, S. (2011) Monitoring of mycophenolic acid presode concentrations in the maintenance phase more than one year after renal transplantation. Ther Drug Monit., 33, 295-302.
  9. Miura, M., Satoh, S., Kagaya, H., Saito, M., Numakura, K., Tsuchiya, N., Habuchi, T. (2011) Impact of the CYP3A4*1G polymorphism and its combination with CYP3A5 genotypes on tacrolimus pharmacokinetics in renal transplant patients. Pharmacogenomics., 12, 977-984.
  10. Miura, M., Satoh, S., Kagaya, H., Saito, M., Numakura, K., Tsuchiya, N., Habuchi, T. (2011) Impact of the CYP3A4*1G polymorphism and its combination with CYP3A5 genotypes on tacrolimus pharmacokinetics in renal transplant patients. Pharmacogenomics., 12, 977-984.
  11. Narita, S., Tsuchiya, N., Yuasa, T., Maita, S., Obara, T., Numnakura K., Tsuruta, H., Saito, M., Inoue, T., Horikawa, Y., Satoh, S. and Habuchi, T. (2011) Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combination chemotherapy with docetaxel, estramustine phosphate and carboplatin for castration-resistant prostate cancer. Int J Clin Oncol., E-pub.
  12. Inoue, T., Satoh, S., Saito, M., Numakura, K., Tsuruta, H., Obara, T., Narita, S., Horikawa, Y., Tsuchiya, N. and Habuchi, T. (2011) Correlations between pretransplant dialysis duration, bladder capacity, and prevalence of vasicoureteral reflux to the graft. Transplantation., 92, 311-315.
  13. Numakura, K., Tsuchiya, N., Obara, T., Tsuruta, H., Saito, M., Narita, S., Inoue, T., Horikawa, Y., Satoh, S., and Habuchi, T. (2011) A case of ureteral malignant lymphoma diagnosed by laparoscopic needle biopsy. Jpn. J. Clin. Oncol., 41, 440-442.
  14. Numakura, K., Tsuchiya, N., Yuasa, T., Saito, M., Obara, T., Tsuruta, H., Narita, S., Horikawa, Y., Satoh, S., Habuchi, T. (2011) A case study of metastatic Xp11.2 translocation renal cell carcinoma effectively treated with sunitinib. Int. J. Clin. Oncol., 16, 577-580.
  15. Numakura, K., Tsuchiya, N., Obara, T., Tsuruta, H., Saito, M., Narita, S., Inoue, T., Horikawa, Y., Satoh, S., and Habuchi, T. (2011) A case of intratesticular endometrioid papillary cystadenocarcinoma. Jpn. J. Clin. Oncol., 41, 674-676.
  16. Saito, M., Tsuchiya, N., Maita, S., Numakura, K., Obara, T., Tsuruta, H., Kumazawa, T., Inoue, T., Narita, S., Horikawa, Y., Yuasa, T., Satoh, S. and Habuchi, T. (2011) What is the most preferred wound site for laparoscopic donor nephrectomy? a questionnaire assessment. J Laparoendosc Adv Surg Tech., 21, 511-515.
  17. Tsukamoto, T., Shinohara, N., Tsuchiya, N., Hamamoto, Y., Maruoka, M., Fujimoto, H., Niwakawa, M., Uemura, H., Usami, M., Terai, A., Kanayama, H. O., Sumiyoshi, Y., Eto, M., Akaza, H. (2011) Phase III trial of everolimus in metastatic renal cell carcinoma: subgroup analysis of Japanese patients from RECORD-1. Jpn J Clin Oncol., 41, 17-24.
  18. Tsuruta, H., Inoue, T., Narita, S., Horikawa, Y., Saito, M., Obara, T., Numakura, K., Maita, S., Satoh, S., Tsuchiya, N. and Habuchi, T. (2011) Combination therapy consisting of gemcitabine, carboplatin, and docetaxel as an active treatment for advanced urothelial carcinoma. Int J Clin Oncol., 16, 533-538.
  19. Preminger, G. M., Alken, P., Habuchi, T., Wijkstra, H., Skolarikos, A., & Yin, C. J. (2011) The clinical research office of the endourological society audit committee. J. Endourol., 25, 1811-1813.
  20. Tsuboi, S., Sutoh, M., Hatakeyama, S., Hiraoka, N., Habuchi, T., Horikawa, Y., Hashimoto, Y., Yoneyama, T., Mori, K., Koie, T., Nakamura, T., Saitoh, H., Yamaya, K., Funyu, T., Fukuda, M., & Ohyama, C. (2011) A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans. Embo. J., 30, 3173-3185.
  21. Kato, T., Miura, M., Kishikawa H., Nishimura K., Satoh, S. and Ichikawa, Y. (2011) Rhabdomyolysis after kidney transplantation caused by elevated serum cyslosporine due to metabolic enzyme and transporters disorder. Transplantation., 92, e8-9.
  22. Kagaya, H., Miura, M., Niioka, T., Saito, M., Numakura, K., Habuchi, T. and Satoh, S. (2011) Influence of NAT2 polymorphisms on sulfamethoxazole pharmacokinetics in renal transplant recipients. Antimicrob Agents Chemother., 56, 825-9.

メニューを開く